MedTrace Logo

The Effect of PAP on ISSHL Comorbided With OSA

NCT04192656 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2019-12-10

No results posted yet for this study

Summary

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Conditions

Interventions

DEVICE

non-invasive positive airway pressure

non-invasive positive airway pressure is the first-line treatment for obstructive sleep apnea

DRUG

Methylprednisolone Hemisuccinate

Methylprednisolone is the first-line treatment of idiopathic sudden sensorineural hearing loss

DRUG

Ginaton

ginnaton is ginkgo biloba extract

Sponsors & Collaborators

  • Beijing Tsinghua Chang Gung Hospital

    lead OTHER

Principal Investigators

  • Juanjuan Gao, MD · Beijing Tsinghua Changung Hospital

  • jingying Ye, MD · Beijing Tsinghua Changung Hospital

  • Haijin Yi, MD · Beijing Tsinghua Changung Hospital

  • Mu He, MD · Beijing Tsinghua Changung Hospital

  • Xin Cao, MA · Beijing Tsinghua Changung Hospital

  • Xingxing Lu, MA · Beijing Tsinghua Changung Hospital

  • Sichao Liang, MA · Beijing Tsinghua Changung Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2024-12-31
Completion
2029-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04192656 on ClinicalTrials.gov